Literature DB >> 23558304

Moderate hypothermia during aortic arch surgery is associated with reduced risk of early mortality.

January Y Tsai1, Wei Pan, Scott A Lemaire, Paul Pisklak, Vei-Vei Lee, Arthur W Bracey, MacArthur A Elayda, Ourania Preventza, Matt D Price, Charles D Collard, Joseph S Coselli.   

Abstract

OBJECTIVE: Selective antegrade cerebral perfusion (ACP) during hypothermic circulatory arrest (HCA) provides cerebral protection during aortic arch surgery. However, the ideal temperature for HCA during ACP remains unknown. Clinical outcomes were compared in patients who underwent moderate (nasopharyngeal temperature, ≥ 20 °C) versus deep (nasopharyngeal temperature, <20 °C) HCA with ACP during aortic arch repair.
METHODS: By using a prospectively maintained clinical database, we analyzed data from 221 consecutive patients who underwent aortic arch replacement with HCA and ACP between December 2006 and May 2009. Seventy-eight patients underwent deep hypothermia (mean lowest temperature, 16.8 °C ± 1.7 °C) and 143 patients underwent moderate hypothermia (mean, 22.9 °C ± 1.4 °C) before systemic circulatory arrest was initiated. Multivariate stepwise logistic and linear regressions were performed to determine whether depth of hypothermia independently predicted postoperative outcomes and blood-product use.
RESULTS: Compared with moderate hypothermia, deep hypothermia was associated independently with a greater risk of in-hospital death (7.7% vs 0.7%; odds ratio [OR], 9.3; 95% confidence interval [CI], 1.1-81.6; P = .005) and 30-day all-cause mortality (9.0% vs 2.1%; OR, 4.7; 95% CI, 1.2-18.6; P = .02), and with longer cardiopulmonary bypass time (154 ± 62 vs 140 ± 46 min; P = .008). Deep hypothermia also was associated with a higher incidence of stroke, although this association was not statistically significant (7.6% vs 2.8%; P = .073; OR, 4.3; 95% CI, 0.9-12.5). No difference was seen in acute kidney injury, blood product transfusion, or need for surgical re-exploration.
CONCLUSIONS: Moderate hypothermia with ACP is associated with lower in-hospital and 30-day mortality, shorter cardiopulmonary bypass time, and fewer neurologic sequelae than deep hypothermia in patients who undergo aortic arch surgery with ACP.
Copyright © 2013 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  19; 26.1.1; 26.1.3; ACP; AKI; AKIN; Acute Kidney Injury Network; CI; CPB; DHCA; HCA; LOS; MHCA; MI; OR; acute kidney injury; antegrade cerebral perfusion; cardiopulmonary bypass; confidence interval; deep hypothermic circulatory arrest; hypothermic circulatory arrest; length of stay; moderate hypothermic circulatory arrest; myocardial infarction; odds ratio

Mesh:

Year:  2013        PMID: 23558304     DOI: 10.1016/j.jtcvs.2013.03.004

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  18 in total

Review 1.  Non-pharmaceutical therapies for stroke: mechanisms and clinical implications.

Authors:  Fan Chen; Zhifeng Qi; Yuming Luo; Taylor Hinchliffe; Guanghong Ding; Ying Xia; Xunming Ji
Journal:  Prog Neurobiol       Date:  2014-01-07       Impact factor: 11.685

Review 2.  Intraoperative care for aortic surgery using circulatory arrest.

Authors:  Félix Ezequiel Fernández Suárez; David Fernández Del Valle; Adrián González Alvarez; Blanca Pérez-Lozano
Journal:  J Thorac Dis       Date:  2017-05       Impact factor: 2.895

3.  Mast cell activation and arterial hypotension during proximal aortic repair requiring hypothermic circulatory arrest.

Authors:  Miklos D Kertai; Sreekanth Cheruku; Wenjing Qi; Yi-Ju Li; G Chad Hughes; Joseph P Mathew; Jörn A Karhausen
Journal:  J Thorac Cardiovasc Surg       Date:  2016-09-14       Impact factor: 5.209

Review 4.  Neuroprotective Strategies in Repair and Replacement of the Aortic Arch.

Authors:  Frank Manetta; Clancy W Mullan; Michael A Catalano
Journal:  Int J Angiol       Date:  2018-05-27

5.  Con-debate: short circulatory arrest times in arch reconstructive surgery: is simple retrograde cerebral perfusion or hypothermic circulatory arrest as good or better than complex antegrade cerebral perfusion for open distal involvement or hemi-arch?

Authors:  Luca Di Marco; Giacomo Murana; Alessandro Leone; Davide Pacini
Journal:  J Vis Surg       Date:  2018-03-08

6.  Antegrade cerebral perfusion at 25 °C for arch reconstruction in newborns and children preserves perioperative cerebral oxygenation and serum creatinine.

Authors:  Bhawna Gupta; Ali Dodge-Khatami; Juan Tucker; Mary B Taylor; Douglas Maposa; Miguel Urencio; Jorge D Salazar
Journal:  Transl Pediatr       Date:  2016-07

7.  Risk factors for acute kidney injury in overweight patients with acute type A aortic dissection: a retrospective study.

Authors:  Honglei Zhao; Xudong Pan; Zhizhong Gong; Jun Zheng; Yongmin Liu; Junming Zhu; Lizhong Sun
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

8.  Does moderate hypothermia really carry less bleeding risk than deep hypothermia for circulatory arrest? A propensity-matched comparison in hemiarch replacement.

Authors:  Jeffrey E Keenan; Hanghang Wang; Brian C Gulack; Asvin M Ganapathi; Nicholas D Andersen; Brian R Englum; Yamini Krishnamurthy; Jerrold H Levy; Ian J Welsby; G Chad Hughes
Journal:  J Thorac Cardiovasc Surg       Date:  2016-08-28       Impact factor: 5.209

9.  Selenium Pretreatment for Mitigation of Ischemia/Reperfusion Injury in Cardiovascular Surgery: Influence on Acute Organ Damage and Inflammatory Response.

Authors:  Holger Steinbrenner; Esra Bilgic; Antonio Pinto; Melanie Engels; Lena Wollschläger; Laura Döhrn; Kristine Kellermann; Udo Boeken; Payam Akhyari; Artur Lichtenberg
Journal:  Inflammation       Date:  2016-08       Impact factor: 4.092

10.  Safety Time and Optimal Temperature of Unilateral Antegrade Cerebral Perfusion in Acute Type A Aortic Dissection: A Single-Center 15-Year Experience.

Authors:  Meng-Ta Tsai; Hsuan-Yin Wu; Yu-Ning Hu; Ting-Wei Lin; Jih-Sheng Wen; Chwan-Yau Luo; Jun-Neng Roan
Journal:  Acta Cardiol Sin       Date:  2022-03       Impact factor: 2.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.